Centene Corporation $CNC Stock Acquired by Mather Group LLC.

Mather Group LLC. increased its position in shares of Centene Corporation (NYSE:CNC) by 61.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 21,310 shares of the company’s stock after buying an additional 8,111 shares during the period. Mather Group LLC.’s holdings in Centene were worth $1,324,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Hudock Inc. acquired a new stake in shares of Centene in the third quarter valued at approximately $225,000. First Pacific Financial bought a new stake in Centene in the 3rd quarter valued at $2,007,000. Strategy Asset Managers LLC bought a new stake in Centene in the 3rd quarter valued at $222,000. Alliance Wealth Advisors LLC acquired a new stake in Centene during the 3rd quarter valued at $223,000. Finally, Cultivar Capital Inc. acquired a new stake in Centene during the 3rd quarter valued at $123,000. 93.63% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Raymond James Financial set a $75.00 price objective on shares of Centene in a report on Tuesday, July 7th. Royal Bank Of Canada lifted their target price on shares of Centene from $70.00 to $71.00 and gave the stock a “sector perform” rating in a report on Thursday, July 9th. JPMorgan Chase & Co. upped their price target on shares of Centene from $60.00 to $67.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Stifel Nicolaus set a $79.00 target price on Centene in a research report on Monday, August 3rd. Finally, Robert W. Baird upped their target price on Centene from $46.00 to $66.00 and gave the company a “neutral” rating in a research report on Wednesday, July 29th. Nine analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Centene currently has a consensus rating of “Hold” and a consensus target price of $70.05.

Centene Stock Performance

NYSE CNC traded down $1.24 during trading on Friday, reaching $69.27. The company’s stock had a trading volume of 3,336,077 shares, compared to its average volume of 4,808,065. The firm has a 50 day moving average price of $65.41 and a 200 day moving average price of $59.67. Centene Corporation has a 12 month low of $31.63 and a 12 month high of $71.21. The firm has a market capitalization of $34.22 billion, a price-to-earnings ratio of -6.64, a price-to-earnings-growth ratio of 0.44 and a beta of 1.13. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.71.

Centene (NYSE:CNC) last announced its earnings results on Monday, July 27th. The company reported $2.51 EPS for the quarter, topping the consensus estimate of $1.09 by $1.42. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. The company had revenue of $53.58 billion for the quarter, compared to analysts’ expectations of $47.64 billion. During the same period last year, the firm earned ($0.16) earnings per share. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. As a group, equities analysts anticipate that Centene Corporation will post 4.89 EPS for the current fiscal year.

Insider Transactions at Centene

In related news, General Counsel Christopher Koster sold 56,500 shares of the stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the sale, the general counsel owned 248,854 shares of the company’s stock, valued at $16,648,332.60. This represents a 18.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.37% of the stock is owned by corporate insiders.

Centene Company Profile

Centene Corporation (NYSE:CNC) is a healthcare enterprise that provides health insurance and related services, primarily through government-sponsored programs. Its offerings include Medicaid plans, Medicare products, health plans sold through the Affordable Care Act marketplace, and services for military families through government-sponsored healthcare programs.

The company also provides pharmacy, behavioral health, specialty healthcare, care management and administrative services through various subsidiaries and partner organizations.